-+ 0.00%
-+ 0.00%
-+ 0.00%

Wells Fargo Maintains Overweight on Agilon Health, Raises Price Target to $141

Benzinga·07/13/2026 14:24:27
Listen to the news
Wells Fargo analyst Stephen Baxter maintains Agilon Health (NYSE:AGL) with a Overweight and raises the price target from $72 to $141.